Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-078038
Filing Date
2014-11-07
Accepted
2014-11-07 08:05:41
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19926_110q.htm 10-Q 842386
2 EX-31.1 a14-19926_1ex31d1.htm EX-31.1 9561
3 EX-31.2 a14-19926_1ex31d2.htm EX-31.2 9624
4 EX-32.1 a14-19926_1ex32d1.htm EX-32.1 6359
5 EX-32.2 a14-19926_1ex32d2.htm EX-32.2 6397
  Complete submission text file 0001104659-14-078038.txt   4732358

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fcsc-20140930.xml EX-101.INS 695931
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20140930.xsd EX-101.SCH 31268
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20140930_cal.xml EX-101.CAL 33337
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20140930_def.xml EX-101.DEF 106302
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fcsc-20140930_lab.xml EX-101.LAB 336359
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20140930_pre.xml EX-101.PRE 234609
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 141202712
SIC: 2834 Pharmaceutical Preparations